Establishing a Platform Strategy for Cell and Gene Therapy Supply Chains
Originally Hosted: October 12, 2022
Duration: 15 Minutes
In case you missed it, check out Cryoport Systems’ presentation from Cell & Gene Meeting on the Mesa 2022. Mark Sawicki, Ph.D, President and Chief Executive Officer of Cryoport Systems, presents on the next generation of Cryoport; a platform strategy approach in standardizing the collection, cryopreservation, storage and distribution of starting material for leukapheresis-based therapies, ultimately de-risking the cell and gene supply chain for our clients and their critical materials.